Anti-CD20 Agents for Relapsing MS

Stuart Schlossman July 27, 2021#COVID-19, Additional MS resource sites, Multiple Sclerosis Videos, Neurology LIVE

July 24, 2021

Fred D. Lublin, MD, Ravi Dukkipati, MD, Gavin Giovannoni, MD , Lauren Gluck, MD

A panel of experts discuss the use of anti-CD20 monoclonal antibodies in relapsing multiple sclerosis including summaries of the phase III ORATORIO and ASCLEPIOS trials, for ocrelizumab and ofatumumab, respectively.

Click Image to watch this presentation

Click HERE to Subscribe for the MS Beacon eNewsletter

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews